Updated Jul 16, 2026
Badawi Paul has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $945K.
Paul Badawi is the President and CEO of Sight Sciences, Inc., an ophthalmic medical device company. He has been involved in the company's strategic direction and product development, particularly in technologies for treating eye diseases.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 28.7K | $5.42 | $155K |
| 2026-04-03 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 29.2K | $3.70 | $108K |
| 2026-02-05 | SGHT | Sight Sciences, Inc. | A — Grant or award | 154.6K | $0.00 | |
| 2026-01-21 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 22.4K | $6.62 | $148K |
| 2026-01-07 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 11.9K | $7.48 | $89K |
| 2026-01-07 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 25.4K | $7.43 | $188K |
| 2025-10-01 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 24.4K | $3.34 | $82K |
| 2025-07-01 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 23.6K | $4.15 | $98K |
| 2024-10-03 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 12.7K | $5.99 | $76K |
Paul Badawi is the President and CEO of Sight Sciences, Inc., an ophthalmic medical device company. He has been involved in the company's strategic direction and product development, particularly in technologies for treating eye diseases.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($945K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Badawi Paul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.